Oppenheimer Asset Management Inc. Buys 1,005 Shares of Agilent Technologies, Inc. $A

Oppenheimer Asset Management Inc. lifted its stake in Agilent Technologies, Inc. (NYSE:A) by 2.1% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 48,923 shares of the medical research company’s stock after buying an additional 1,005 shares during the period. Oppenheimer Asset Management Inc.’s holdings in Agilent Technologies were worth $5,773,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also added to or reduced their stakes in the company. Stone House Investment Management LLC acquired a new position in Agilent Technologies during the first quarter valued at approximately $30,000. Ransom Advisory Ltd acquired a new position in Agilent Technologies during the first quarter valued at approximately $32,000. Central Pacific Bank Trust Division acquired a new position in Agilent Technologies during the second quarter valued at approximately $33,000. Zions Bancorporation National Association UT acquired a new position in Agilent Technologies during the first quarter valued at approximately $38,000. Finally, Costello Asset Management INC acquired a new position in Agilent Technologies during the first quarter valued at approximately $47,000.

Agilent Technologies Stock Performance

Shares of Agilent Technologies stock opened at $146.82 on Tuesday. The company has a quick ratio of 1.71, a current ratio of 2.25 and a debt-to-equity ratio of 0.53. Agilent Technologies, Inc. has a twelve month low of $96.43 and a twelve month high of $153.84. The stock has a market cap of $41.62 billion, a price-to-earnings ratio of 34.47, a P/E/G ratio of 4.83 and a beta of 1.26. The company’s fifty day moving average is $130.95 and its 200 day moving average is $119.71.

Agilent Technologies (NYSE:A) last issued its quarterly earnings data on Wednesday, August 27th. The medical research company reported $1.37 earnings per share for the quarter, hitting the consensus estimate of $1.37. Agilent Technologies had a net margin of 17.97% and a return on equity of 25.51%. The company had revenue of $1.74 billion for the quarter, compared to analysts’ expectations of $1.67 billion. During the same quarter in the previous year, the firm posted $1.32 earnings per share. Agilent Technologies’s revenue for the quarter was up 10.1% on a year-over-year basis. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. Sell-side analysts forecast that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Agilent Technologies Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, October 22nd. Investors of record on Tuesday, September 30th were paid a $0.248 dividend. The ex-dividend date of this dividend was Tuesday, September 30th. This represents a $0.99 annualized dividend and a dividend yield of 0.7%. Agilent Technologies’s payout ratio is currently 23.24%.

Analyst Upgrades and Downgrades

Several research analysts have commented on A shares. TD Cowen boosted their price objective on shares of Agilent Technologies from $150.00 to $162.00 and gave the company a “buy” rating in a research report on Tuesday, October 14th. UBS Group upgraded shares of Agilent Technologies from a “neutral” rating to a “buy” rating and boosted their price objective for the company from $130.00 to $170.00 in a research report on Wednesday, October 8th. Weiss Ratings reiterated a “hold (c)” rating on shares of Agilent Technologies in a report on Wednesday, October 8th. Wells Fargo & Company upped their price target on shares of Agilent Technologies from $140.00 to $150.00 and gave the stock an “overweight” rating in a report on Monday, September 15th. Finally, Rothschild Redb upgraded shares of Agilent Technologies to a “strong-buy” rating in a report on Wednesday, October 8th. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and six have issued a Hold rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $149.62.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.